Skip to main content
PMC home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1995 Jun;4(6):1081–1087. doi: 10.1002/pro.5560040606

Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.

J N Varghese 1, V C Epa 1, P M Colman 1
PMCID: PMC2143140  PMID: 7549872

Abstract

The three-dimensional X-ray structure of a complex of the potent neuraminidase inhibitor 4-guanidino-Neu5Ac2en and influenza virus neuraminidase (Subtype N9) has been obtained utilizing diffraction data to 1.8 A resolution. The interactions of the inhibitor, solvent water molecules, and the active site residues have been accurately determined. Six water molecules bound in the native structure have been displaced by the inhibitor, and the active site residues show no significant conformational changes on binding. Sialic acid, the natural substrate, binds in a half-chair conformation that is isosteric to the inhibitor. The conformation of the inhibitor in the active site of the X-ray structure concurs with that obtained by theoretical calculations and validates the structure-based design of the inhibitor. Comparison of known high-resolution structures of neuraminidase subtypes N2, N9, and B shows good structural conservation of the active site protein atoms, but the location of the water molecules in the respective active sites is less conserved. In particular, the environment of the 4-guanidino group of the inhibitor is strongly conserved and is the basis for the antiviral action of the inhibitor across all presently known influenza strains. Differences in the solvent structure in the active site may be related to variation in the affinities of inhibitors to different subtypes of neuraminidase.

Full Text

The Full Text of this article is available as a PDF (7.8 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bossart-Whitaker P., Carson M., Babu Y. S., Smith C. D., Laver W. G., Air G. M. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid. J Mol Biol. 1993 Aug 20;232(4):1069–1083. doi: 10.1006/jmbi.1993.1461. [DOI] [PubMed] [Google Scholar]
  2. Burmeister W. P., Ruigrok R. W., Cusack S. The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J. 1992 Jan;11(1):49–56. doi: 10.1002/j.1460-2075.1992.tb05026.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Colman P. M., Laver W. G., Varghese J. N., Baker A. T., Tulloch P. A., Air G. M., Webster R. G. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. 1987 Mar 26-Apr 1Nature. 326(6111):358–363. doi: 10.1038/326358a0. [DOI] [PubMed] [Google Scholar]
  4. Colman P. M., Tulip W. R., Varghese J. N., Tulloch P. A., Baker A. T., Laver W. G., Air G. M., Webster R. G. Three-dimensional structures of influenza virus neuraminidase-antibody complexes. Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12;323(1217):511–518. doi: 10.1098/rstb.1989.0028. [DOI] [PubMed] [Google Scholar]
  5. Crennell S., Garman E., Laver G., Vimr E., Taylor G. Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain. Structure. 1994 Jun 15;2(6):535–544. doi: 10.1016/s0969-2126(00)00053-8. [DOI] [PubMed] [Google Scholar]
  6. Jones T. A., Zou J. Y., Cowan S. W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991 Mar 1;47(Pt 2):110–119. doi: 10.1107/s0108767390010224. [DOI] [PubMed] [Google Scholar]
  7. Laver W. G., Colman P. M., Webster R. G., Hinshaw V. S., Air G. M. Influenza virus neuraminidase with hemagglutinin activity. Virology. 1984 Sep;137(2):314–323. doi: 10.1016/0042-6822(84)90223-x. [DOI] [PubMed] [Google Scholar]
  8. Pegg M. S., von Itzstein M. Slow-binding inhibition of sialidase from influenza virus. Biochem Mol Biol Int. 1994 Apr;32(5):851–858. [PubMed] [Google Scholar]
  9. Stewart J. J. MOPAC: a semiempirical molecular orbital program. J Comput Aided Mol Des. 1990 Mar;4(1):1–105. doi: 10.1007/BF00128336. [DOI] [PubMed] [Google Scholar]
  10. Tulip W. R., Varghese J. N., Baker A. T., van Donkelaar A., Laver W. G., Webster R. G., Colman P. M. Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. J Mol Biol. 1991 Sep 20;221(2):487–497. doi: 10.1016/0022-2836(91)80069-7. [DOI] [PubMed] [Google Scholar]
  11. Varghese J. N., Colman P. M. Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution. J Mol Biol. 1991 Sep 20;221(2):473–486. doi: 10.1016/0022-2836(91)80068-6. [DOI] [PubMed] [Google Scholar]
  12. Varghese J. N., Laver W. G., Colman P. M. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature. 1983 May 5;303(5912):35–40. doi: 10.1038/303035a0. [DOI] [PubMed] [Google Scholar]
  13. Varghese J. N., McKimm-Breschkin J. L., Caldwell J. B., Kortt A. A., Colman P. M. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins. 1992 Nov;14(3):327–332. doi: 10.1002/prot.340140302. [DOI] [PubMed] [Google Scholar]
  14. Varghese J. N., Webster R. G., Laver W. G., Colman P. M. Structure of an escape mutant of glycoprotein N2 neuraminidase of influenza virus A/Tokyo/3/67 at 3 A. J Mol Biol. 1988 Mar 5;200(1):201–203. doi: 10.1016/0022-2836(88)90344-0. [DOI] [PubMed] [Google Scholar]
  15. von Itzstein M., Wu W. Y., Kok G. B., Pegg M. S., Dyason J. C., Jin B., Van Phan T., Smythe M. L., White H. F., Oliver S. W. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 1993 Jun 3;363(6428):418–423. doi: 10.1038/363418a0. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES